{
    "Trade/Device Name(s)": [
        "Wisdiag Multi-Drug Urine Test Cup",
        "Wisdiag Multi-Drug Urine Test Cup Rx"
    ],
    "Submitter Information": "VivaChek Biotech (Hangzhou) Co., Ltd.",
    "510(k) Number": "K222667",
    "Predicate Device Reference 510(k) Number(s)": [
        "K182701"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NFT",
        "NGL",
        "PTH",
        "NFV",
        "NFY",
        "PTG",
        "NGG",
        "QBF",
        "QAW",
        "NFW",
        "LCM"
    ],
    "Summary Letter Date": "November 10, 2022",
    "Summary Letter Received Date": "September 6, 2022",
    "Submission Date": "November 7, 2022",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3650",
        "21 CFR 862.3150",
        "21 CFR 862.3170",
        "21 CFR 862.3250",
        "21 CFR 862.3620",
        "21 CFR 862.3610",
        "21 CFR 862.3700",
        "21 CFR 862.3910",
        "21 CFR 862.3870"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system",
        "Opiate test system",
        "Barbiturate test system",
        "Benzodiazepine test system",
        "Cocaine test system",
        "Methadone test system",
        "Methamphetamine test system",
        "Propoxyphene test system",
        "Tricyclic antidepressant drugs test system",
        "Cannabinoids test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Buprenorphine",
        "Secobarbital",
        "Oxazepam",
        "Cocaine",
        "2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine",
        "Methamphetamine",
        "Methylenedioxymethamphetamine",
        "Morphine",
        "Methadone",
        "Oxycodone",
        "Phencyclidine",
        "Propoxyphene",
        "Nortriptyline",
        "Marijuana",
        "Cannabinoids"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Test Cup"
    ],
    "Instrument(s)/Platform(s)": [
        "Wisdiag Multi-Drug Urine Test Cup",
        "Wisdiag Multi-Drug Urine Test Cup Rx"
    ],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunochromatographic assay",
        "Competitive binding assay"
    ],
    "Methodologies": [
        "Immunochromatographic testing",
        "Antigen-antibody reaction"
    ],
    "Submission Type(s)": [
        "Cup",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Wisdiag Multi-Drug Urine Test Cup and Rx versions, lateral flow immunochromatographic rapid tests for qualitative detection of multiple drugs of abuse in urine.",
    "Indications for Use Summary": "For qualitative and simultaneous detection of Amphetamine, Buprenorphine, Secobarbital, Oxazepam, Cocaine, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, Methamphetamine, Methylenedioxymethamphetamine, Morphine, Methadone, Oxycodone, Phencyclidine, Propoxyphene, Nortriptyline, and Cannabinoids (Marijuana) in human urine; OTC and prescription use, results are preliminary and require confirmatory testing.",
    "fda_folder": "Toxicology"
}